论文部分内容阅读
目的探讨布地奈德福莫特罗粉吸入剂对妊娠期哮喘的疗效。方法选取2011年9月至2013年9月妊娠期哮喘患者48例,均吸入布地奈德福莫特罗粉吸入剂,疗程12周,观察患者的临床疗效。结果经布地奈德福莫特罗粉吸入剂治疗后,患者咳嗽、胸闷、气喘等症状明显改善,哮鸣音消失。临床疗效显著,治疗有效率高达93.75%,治疗后患者的日间症状评分、夜间症状评分、PEF值显著优于治疗前,比较差异具有统计学意义(P<0.05),治疗期间仅发生声音嘶哑与心悸各1例,经对症处理后缓解。结论布地奈德福莫特罗粉吸入剂治疗妊娠期哮喘疗效显著,不良反应少,值得临床推广使用。
Objective To investigate the efficacy of budesonide formoterol powder inhalation on gestational asthma. Methods From September 2011 to September 2013, 48 pregnant women with asthma were inhaled budesonide formoterol powder inhalation, the course of treatment for 12 weeks to observe the clinical efficacy of the patients. Results After the inhalation of budesonide formoterol powder inhalation, patients with cough, chest tightness, asthma and other symptoms improved significantly, wheezing disappeared. The clinical curative effect was remarkable, the effective rate of treatment was as high as 93.75%. The daytime symptom score, nighttime symptom score and PEF value of the patients after treatment were significantly better than those before treatment (P <0.05), and only hoarseness occurred during the treatment 1 with heart palpitations, relieved after symptomatic treatment. Conclusion The efficacy of budesonide formoterol powder inhalation for treatment of gestational asthma is significant and the adverse reactions are few. It is worth to be used clinically.